InsidersTradesSigma
Follow the Legend Biotech Corp share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €4.1bn. The latest transaction was filed on 18 August 2026 (Attribution). Among the most active insiders: Huang Ying. Every trade is openly available.
Analysts rate Legend Biotech Corp Buy (bullish), based on 15 analysts. Average price target: US$49.25.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
Legend Biotech Corp es una empresa biofarmacéutica centrada en el desarrollo de terapias innovadoras para el tratamiento del cáncer. Cotiza en NASDAQ bajo el símbolo LEGN.